Penumbra (PEN) Competitors

Inspire Medical Systems (NYSE:INSP) and Penumbra (NYSE:PEN) are both mid-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, community ranking, institutional ownership, media sentiment, risk, dividends, analyst recommendations, profitability and earnings.

Which has preferable valuation and earnings, INSP or PEN?

Penumbra has higher revenue and earnings than Inspire Medical Systems. Inspire Medical Systems is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inspire Medical Systems	$624.80M	11.83	-$21.15M	-$0.74	-329.51
Penumbra	$1.06B	7.39	$90.95M	$2.31	87.42

Is INSP or PEN more profitable?

Penumbra has a net margin of 8.59% compared to Penumbra's net margin of -3.39%. Inspire Medical Systems' return on equity of 7.49% beat Penumbra's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inspire Medical Systems	-3.39%	-3.93%	-3.38%
Penumbra	8.59%	7.49%	5.60%

Do insiders and institutionals believe in INSP or PEN?

94.9% of Inspire Medical Systems shares are owned by institutional investors. Comparatively, 88.9% of Penumbra shares are owned by institutional investors. 4.1% of Inspire Medical Systems shares are owned by company insiders. Comparatively, 5.3% of Penumbra shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Do analysts recommend INSP or PEN?

Inspire Medical Systems presently has a consensus target price of $272.20, indicating a potential upside of 11.63%. Penumbra has a consensus target price of $304.45, indicating a potential upside of 50.76%. Given Inspire Medical Systems' stronger consensus rating and higher probable upside, analysts clearly believe Penumbra is more favorable than Inspire Medical Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inspire Medical Systems	0 Sell rating(s)	4 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.71
Penumbra	0 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.78

Does the media refer more to INSP or PEN?

In the previous week, Penumbra had 3 more articles in the media than Inspire Medical Systems. MarketBeat recorded 10 mentions for Penumbra and 7 mentions for Inspire Medical Systems. Penumbra's average media sentiment score of 1.27 beat Inspire Medical Systems' score of 0.72 indicating that Inspire Medical Systems is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Inspire Medical Systems	6 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Penumbra	4 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more risk & volatility, INSP or PEN?

Inspire Medical Systems has a beta of 1.37, meaning that its share price is 37% more volatile than the S&P 500. Comparatively, Penumbra has a beta of 0.51, meaning that its share price is 49% less volatile than the S&P 500.

Does the MarketBeat Community prefer INSP or PEN?

Penumbra received 615 more outperform votes than Inspire Medical Systems when rated by MarketBeat users. Likewise, 80.47% of users gave Penumbra an outperform vote while only 61.11% of users gave Inspire Medical Systems an outperform vote.

Company	Underperform	Outperform
Inspire Medical Systems	Outperform Votes 176 61.11%	Underperform Votes 112 38.89%
Penumbra	Outperform Votes 791 80.47%	Underperform Votes 192 19.53%

Summary

Penumbra beats Inspire Medical Systems on 13 of the 18 factors compared between the two stocks.